SEPTEMBER 8, 2026 – Staff at Naval Medical Research Command (NMRC) are currently recruiting volunteers for a phase 2a study to evaluate the safety and effectiveness of INNA-051 a treatment for respiratory tract Illness. INNA-051, a self-administered nasal spray, was previously determined by the NMRC Clinical Trials Center (CTC) to be safe for human use, […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.